banisteriopsis caapi extract
banisteria caapi extract
Identification
| Name | banisteriopsis caapi extract |
| IUPAC | banisteriopsis caapi extract |
| CAS Number | 97952-49-3 |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | information only not used for fragrances or flavors |
| Recommendation for banisteriopsis caapi extract usage levels up to | not for fragrance use. |
| Recommendation for banisteriopsis caapi extract flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
banisteria caapi extract
PubMed:
Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
PubMed:
Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease.
PubMed:
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.
PubMed:
A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract.
PubMed:
Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
PubMed:
Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.